Dr. Frances E. Chow
Claim this profileUniversity of Southern California
Studies Glioblastoma
Studies Brain Tumor
7 reported clinical trials
18 drugs studied
Area of expertise
1Glioblastoma
MET positive
IDH negative
MGMT
2Brain Tumor
Stage IV
PD
Recurrent
Affiliated Hospitals
Clinical Trials Frances E. Chow is currently running
NEO100
for Meningioma
This multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (perillyl alcohol) for the treatment of patients with residual high-grade meningioma following resection surgery, radiographically-confirmed progression of high-grade meningioma or recurrent high-grade meningioma. There will be up to 30 patients enrolled in this study to have 29 evaluable patients. NEO100 will be self-administered four times daily on a 28-day treatment cycle until disease progression, death or patient withdraw from study for any reason, whichever occurs first.
Recruiting1 award Phase 215 criteria
Perillyl Alcohol
for Glioblastoma
This trial is testing NEO100, a purified form of perillyl alcohol, to treat aggressive brain tumors in patients whose cancer has returned or not responded to other treatments. The treatment is given through the nose regularly and may help slow down tumor growth. Perillyl alcohol (POH) is a naturally occurring substance with properties that may inhibit tumor growth, and NEO100 is a highly purified version of POH currently being tested for glioblastoma treatment.
Recruiting1 award Phase 1 & 22 criteria
More about Frances E. Chow
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Frances E. Chow has experience with
- Selinexor
- Temozolomide
- NEO100
- Bevacizumab
- Carmustine
- Lomustine (CCNU)
Breakdown of trials Frances E. Chow has run
Glioblastoma
Brain Tumor
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Frances E. Chow specialize in?
Frances E. Chow focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MET positive patients, or patients who are IDH negative.
Is Frances E. Chow currently recruiting for clinical trials?
Yes, Frances E. Chow is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Frances E. Chow has studied deeply?
Yes, Frances E. Chow has studied treatments such as Selinexor, Temozolomide, NEO100.
What is the best way to schedule an appointment with Frances E. Chow?
Apply for one of the trials that Frances E. Chow is conducting.
What is the office address of Frances E. Chow?
The office of Frances E. Chow is located at: University of Southern California, Los Angeles, California 90033 United States. This is the address for their practice at the University of Southern California.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.